Roth Capital Issues Optimistic Outlook for TSE:TRU Earnings

Trulieve Cannabis Corp. (TSE:TRU) – Stock analysts at Roth Capital lifted their Q3 2025 earnings estimates for shares of Trulieve Cannabis in a research report issued to clients and investors on Wednesday, August 6th. Roth Capital analyst W. Kirk now expects that the company will post earnings per share of ($0.12) for the quarter, up from their prior estimate of ($0.15). Roth Capital also issued estimates for Trulieve Cannabis’ FY2025 earnings at ($0.55) EPS, Q2 2026 earnings at ($0.08) EPS, Q3 2026 earnings at ($0.11) EPS and FY2026 earnings at ($0.37) EPS.

Trulieve Cannabis Price Performance

Trulieve Cannabis Company Profile

TransUnion provides risk and information solutions. The company operates in three segments: U.S. Markets, International, and Consumer Interactive. The U.S. Markets segment provides consumer reports, actionable insights, and analytics to businesses. These businesses use its services to acquire new customers; assess consumer ability to pay for services; identify cross-selling opportunities; measure and manage debt portfolio risk; collect debt; verify consumer identities; and mitigate fraud risk.